“I don’t think we’ll be as exuberant.”

— Donald Baim, MD, chief medical officer at Boston Scientific, commenting on the future promotion of drug-eluting stent systems in future applications of this technology, “Panel: vascular therapy poses difficulties but always reinvents,” p. 1, 7, 9.

No Comments